A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edwin Posadas, MD
RTOG Foundation
Principal Investigator - Hiram Gay, MD
RTOG Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
108 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu de Quebec - L'Hotel-Dieu de Quebec
Québec, Quebec, Canada
- Ciuss de L'Estrie - Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Canada
- Arizona Center for Cancer Care - Gilbert
Gilbert, Arizona, United States
- Arizona Center for Cancer Care - Peoria
Peoria, Arizona, United States
- Arizona Center for Cancer Care - Phoenix
Phoenix, Arizona, United States
- Arizona Center for Cancer Care - Scottsdale East
Scottsdale, Arizona, United States
- Arizona Center for Cancer Care - Scottsdale North
Scottsdale, Arizona, United States
- Arizona Center for Cancer Care - Surprise
Surprise, Arizona, United States
- Marin Cancer Care, Inc.
Greenbrae, California, United States
- Marin Health Medical Center
Greenbrae, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Usc Medical Center - Los Angeles County
Los Angeles, California, United States
- University of Southern California
Los Angeles, California, United States
- Roseville Radiation Oncology Center
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Valley View Hospital Cancer Center
Glenwood Springs, Colorado, United States
- University of Florida Health Science Center
Gainesville, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Nancy N. & J.C. Lewis Cancer & Research Pavilion
Savannah, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Kansas University Cancer Center Overland Park
Overland Park, Kansas, United States
- Kansas University Cancer Center Westwood
Westwood, Kansas, United States
- East Jefferson General Hospital
Metairie, Louisiana, United States
- Lsu Healthcare Network/metairie Multi-Specialty Clinic
Metairie, Louisiana, United States
- Coastal Cancer Treatment Center - Bath
Bath, Maine, United States
- Waldo Count General Hospital - Belfast
Belfast, Maine, United States
- Maine Health/smhc Cancer Care and Blood Disorders-Biddeford
Biddeford, Maine, United States
- Maine Health/stephens Memorial - Norway
Norway, Maine, United States
- Maine Medical Center - Bramhall S Portland
Portland, Maine, United States
- Penobscot Bay Medical Center - Rockport
Rockport, Maine, United States
- Maine Health Cc of York County - Sanford
Sanford, Maine, United States
- Maine Health/smhcancer Care and Blood Disorders - Sanford
Sanford, Maine, United States
- Maine Medical Cancer Center - Scarborough Campus
Scarborough, Maine, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Apr 2019
- Primary completion
- 7 Apr 2023
- Completion
- 15 Sept 2029
- Last update posted
- 30 Dec 2025
- Registered enrollment
- 188
- Registry id
- NCT03809000
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.